1 |
Jackson SM, Parhami F, Xi XP, Berliner JA, Hsueh WA, Law RE, Demer LL. 1999. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol 19: 2094-2104
DOI
ScienceOn
|
2 |
Carlos TM, Harlan JM. 1994. Leukocyte-endothelial adhesion molecules. Blood 84: 2068-2101
|
3 |
Kagawa Y, Nishizawa M, Suzuki M, Miyatake T, Hamamoto T, Goto K, Motonaga E, Izumikawa H, Hirata H, Ebihara A. 1982. Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. J Nutr Sci Vitaminol 28: 441-453
DOI
|
4 |
Kromhout D, Bosschieter EB, Coulander de Lezenne C. 1985. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312: 1205-1209
DOI
ScienceOn
|
5 |
Prichard BN, Smith CC, Ling KL, Betteridge DJ. 1995. Fish oils and cardiovascular disease. Br Med J 310: 819-820
DOI
|
6 |
Wahle KW, Rotondo D. 1999. Fatty acids and endothelial cell function: regulation of adhesion molecule and redox enzyme expression. Curr Opin Clin Nutr Metab Care 2: 109-115
DOI
ScienceOn
|
7 |
Massaro M, Carluccio MA, De Caterina R. 1999. Direct vascular antiatherogenic effects of oleic acid: a clue to the cardioprotective effects of the Mediterranean diet. Cardiologia 44: 507-513
|
8 |
Yu Y, Correll PH, Vanden Heuvel JP. 2002. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPARγ-dependent mechanism. Biochim Biophys Acta 1581: 89-99
DOI
ScienceOn
|
9 |
Desvergne B, Wahli W. 1999. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688
DOI
ScienceOn
|
10 |
Lee H, Shi W, Tontonoz P, Wang S, Subbanagounder G, Hedrick CC, Hama S, Borromeo C, Evans RM, Berliner JA, Nagy L. 2000. Role for peroxisome proliferator-activated receptor in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res 87: 516-521
DOI
ScienceOn
|
11 |
Inoue I, Goto S, Matsunaga T, Nakajima T, Awata T, Hokari S, Komoda T, Katayama S. 2001. The ligands/activators for peroxisome proliferator-activated receptor (PPAR ) and PPAR increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells. Metabolism 50: 3-11
DOI
ScienceOn
|
12 |
Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P, Walsh MK, Morris D, Shekelle RB. 1997. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 336: 1046-1053
DOI
ScienceOn
|
13 |
Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC, Ruskin JN, Manson JE. 1998. Fish consumption and risk of sudden cardiac death. JAMA 279: 23- 28
DOI
ScienceOn
|
14 |
Soei LK, Lamers JM, Sassen LM, van Tol A, Scheek LM, Dekkers DH, van Meegen JR, Verdou PD. 1995. Fish oil: a modulator of experimental atherosclerosis in animals. In N-3 Fatty Acids: Prevention and Treatment in Vascular Disease. Kristensen S, Endres S, De Caterina R, Schmidt EB, eds. Springer, London. p 77-84
|
15 |
Marx N, Bourcier T, Sukhova GK, Libby P, Plutzky J. 1999. PPARγactivation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARγ as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol 19: 546-551
DOI
ScienceOn
|
16 |
Harris WS. 1989. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30: 785-807
|
17 |
Sanders TA, Hinds A. 1992. The influence of a fish oil high in docosahexaenoic acid on plasma lipoprotein and vitamin E concentrations and haemostatic function in healthy male volunteers. Br J Nutr 68: 163-173
DOI
ScienceOn
|
18 |
Calabresi L, Gomaraschi M, Villa B, Omoboni L, Dmitrieff C, Franceschini G. 2002. Elevated soluble cellular adhesion molecules in subjects with low HDL-cholesterol. Arterioscler Thromb Vasc Biol 22: 656-661
DOI
ScienceOn
|
19 |
Seljeflot I, Tonstad S, Hjermann I, Arnesen H. 2002. Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease. Atherosclerosis 162: 179-185
DOI
ScienceOn
|
20 |
Chinetti G, Fruchart JC, Staels B. 2000. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49: 497-505
DOI
ScienceOn
|
21 |
Spencer NF, Poynter ME, Im SY, Daynes RA. 1997. Constitutive activation of NF- B in an animal model of aging. Int Immunol 9: 1581-1588
DOI
ScienceOn
|
22 |
Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. 1998. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391: 79-82
DOI
ScienceOn
|
23 |
Murase T, Kondo H, Hase T, Tokimitsu I, Saito M. 2001. Abundant expression of uncoupling protein-2 in the small intestine: up-regulation by dietary fish oil and fibrates. Biochim Biophys Acta 1530: 15-22
DOI
ScienceOn
|
24 |
Marx N, Sukhova GK, Collins T, Libby P, Plutzky J. 1999. PPAR activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 99: 3125-3131
DOI
|
25 |
Carluccio MA, Massaro M, Bonfrate C, Siculella L, Maffia M, Nicolardi G, Distante A, Storelli C, De Caterina R. 1999. Oleic acid inhibits endothelial activation: A direct vascular antiatherogenic mechanism of a nutritional component in the mediterranean diet. Arterioscler Thromb Vasc Biol 19: 220- 228
DOI
ScienceOn
|
26 |
Moya-Camarena SY, Vanden Heuvel JP, Blanchard SG, Leesnitzer LA, Belury MA. 1999. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR . J Lipid Res 40: 1426-1433
|
27 |
Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD. 1999. A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response. J Clin Invest 104: 383-389
DOI
ScienceOn
|
28 |
Pasceri V, Wu HD, Willerson JT, Yeh ET. 2000. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators. Circulation 101: 235-238
DOI
ScienceOn
|
29 |
Rival Y, Beneteau N, Taillandier T, Pezet M, Dupont-Passelaigue E, Patoiseau JF, Junquero D, Colpaert FC, Delhon A. 2002. PPAR and PPAR activators inhibit cytokine-induced nuclear translocation of NF- B and expression of VCAM-1 in EAhy926 endothelial cells. Eur J Pharmacol 435: 143- 151
DOI
ScienceOn
|
30 |
Viedt C, Vogel J, Athanasiou T, Shen W, Orth SR, Kubler W, Kreuzer J. 2002. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor- B and activator protein-1. Arterioscler Thromb Vasc Biol 22: 914-920
DOI
ScienceOn
|
31 |
Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J. 2001. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103: 2531-2534
DOI
ScienceOn
|
32 |
Inoue I, Goto S, Mizotani K, Awata T, Mastunaga T, Kawai S, Nakajima T, Hokari S, Komoda T, Katayama S. 2000. Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of mRNA levels for interleukin- 1 , interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor (PPAR ) in primary endothelial cells. Life Sci 67: 863-876
DOI
ScienceOn
|
33 |
De Caterina R, Liao JK, Libby P. 2000. Fatty acid modulation of endothelial activation. Am J Clin Nutr 71: 213S- 223S
|
34 |
Marx N, Mach F, Sauty A, Leung JH, Sarafi MN, Ransohoff RM, Libby P, Plutzky J, Luster AD. 2000. Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-γ- induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol 164: 6503-6508
DOI
|
35 |
Forman BM, Chen J, Evans RM. 1997. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors and . Proc Natl Acad Sci USA 94: 4312-4317
DOI
ScienceOn
|
36 |
Desvergne B, A IJ, Devchand PR, Wahli W. 1998. The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling. J Steroid Biochem Mol Biol 65: 65-74
DOI
ScienceOn
|
37 |
Miles EA, Thies F, Wallace FA, Powell JR, Hurst TL, Newsholme EA, Calder PC. 2001. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin Sci (Lond) 100: 91-100
DOI
ScienceOn
|
38 |
Johansen O, Seljeflot I, Hostmark AT, Arnesen H. 1999. The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 19: 1681- 1686
DOI
ScienceOn
|